Vascular pathobiology in chronic liver disease and cirrhosis - Current status and future directions

被引:221
|
作者
Iwakiri, Yasuko [1 ]
Shah, Vijay [2 ]
Rockey, Don C. [3 ]
机构
[1] Yale Univ Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT USA
[2] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA
[3] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA
基金
美国国家卫生研究院;
关键词
Endothelial cell; Pericyte; Sinusoid; Pressure; Resistance; Therapy; NITRIC-OXIDE SYNTHASE; SINUSOIDAL ENDOTHELIAL-CELLS; PORTAL HYPERTENSIVE-RATS; HEPATIC STELLATE CELLS; SCANNING ELECTRON-MICROSCOPE; FIBROBLAST-GROWTH-FACTOR; FARNESOID X RECEPTOR; SMOOTH MUSCLE ACTIN; IN-VIVO; GENE-TRANSFER;
D O I
10.1016/j.jhep.2014.05.047
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chronic liver disease is associated with remarkable alterations in the intra- and extrahepatic vasculature. Because of these changes, the fields of liver vasculature and portal hypertension have recently become closely integrated within the broader vascular biology discipline. As developments in vascular biology have evolved, a deeper understanding of vascular processes has led to a better understanding of the mechanisms of the dynamic vascular changes associated with portal hypertension and chronic liver disease. In this context, hepatic vascular cells, such as sinusoidal endothelial cells and pericyte-like hepatic stellate cells, are closely associated with one another, where they have paracrine and autocrine effects on each other and themselves. These cells play important roles in the pathogenesis of liver fibrosis/cirrhosis and portal hypertension. Further, a variety of signaling pathways have recently come to light. These include growth factor pathways involving cytokines such as transforming growth factor beta, platelet derived growth factor, and others as well as a variety of vasoactive peptides and other molecules. An early and consistent feature of liver injury is the development of an increase in intra-hepatic resistance; this is associated with changes in hepatic vascular cells and their signaling pathway that cause portal hypertension. A critical concept is that this process aggregates signals to the extrahepatic circulation, causing derangement in this system's cells and signaling pathways, which ultimately leads to the collateral vessel formation and arterial vasodilation in the splanchnic and systemic circulation, which by virtue of the hydraulic derivation of Ohm's law (pressure = resistance x flow), worsens portal hypertension. This review provides a detailed review of the current status and future direction of the basic biology of portal hypertension with a focus on the physiology, pathophysiology, and signaling of cells within the liver, as well as those in the mesenteric vascular circulation. Translational implications of recent research and the future directions that it points to are also highlighted. (C) 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:912 / 924
页数:13
相关论文
共 50 条
  • [21] Aneurysmal subarachnoid hemorrhage: pathobiology, current treatment and future directions
    Serrone, Joseph C.
    Maekawa, Hidetsugu
    Tjahjadi, Mardjono
    Hernesniemi, Juha
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (04) : 367 - 380
  • [22] Pathology and pathobiology of pulmonary hypertension: current insights and future directions
    Guignabert, Christophe
    Aman, Jurjan
    Bonnet, Sebastien
    Dorfmueller, Peter
    Olschewski, Andrea J.
    Pullamsetti, Soni
    Rabinovitch, Marlene
    Schermuly, Ralph T.
    Humbert, Marc
    Stenmark, Kurt R.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64 (04)
  • [23] Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions
    Pietro Vajro
    Selvaggia Lenta
    Claudio Pignata
    Mariacarolina Salerno
    Roberta D’Aniello
    Ida De Micco
    Giulia Paolella
    Giancarlo Parenti
    Italian Journal of Pediatrics, 38
  • [24] Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions
    Vajro, Pietro
    Lenta, Selvaggia
    Pignata, Claudio
    Salerno, Mariacarolina
    D'Aniello, Roberta
    De Micco, Ida
    Paolella, Giulia
    Parenti, Giancarlo
    ITALIAN JOURNAL OF PEDIATRICS, 2012, 38
  • [25] Concise Review: Current Status and Future Directions on Research Related to Nonalcoholic Fatty Liver Disease
    Wruck, Wasco
    Graffmann, Nina
    Kawala, Marie-Ann
    Adjaye, James
    STEM CELLS, 2017, 35 (01) : 89 - 96
  • [26] Immunotherapy in Alzheimer's Disease: Current Status and Future Directions
    Vashisth, Kshitij
    Sharma, Shivani
    Ghosh, Shampa
    Babu, M. Arockia
    Ghosh, Soumya
    Iqbal, Danish
    Kamal, Mehnaz
    Almutary, Abdulmajeed G.
    Jha, Saurabh Kumar
    Ojha, Shreesh
    Bhaskar, Rakesh
    Jha, Niraj Kumar
    Sinha, Jitendra Kumar
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 101 : S23 - S39
  • [27] Current Status, Challenges, and Future Directions in Crohn's Disease
    Selinger, Christian
    van der Meulen, Andrea
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (16)
  • [28] Plant disease resistance genes: Current status and future directions
    Gururani, Mayank Anand
    Venkatesh, Jelli
    Upadhyaya, Chandrama Prakash
    Nookaraju, Akula
    Pandey, Shashank Kumar
    Park, Se Won
    PHYSIOLOGICAL AND MOLECULAR PLANT PATHOLOGY, 2012, 78 : 51 - 65
  • [29] Palmitoylation in Crohn's disease: Current status and future directions
    Cheng, Wei-Xin
    Ren, Yue
    Lu, Miao-Miao
    Xu, Ling-Ling
    Gao, Jian-Guo
    Chen, Dong
    Kalyani, Farhin Shaheed
    Lv, Zi-Yan
    Chen, Chun-Xiao
    Ji, Feng
    Lin, He-Ning
    Jin, Xi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (48) : 8201 - 8215
  • [30] Antiplatelet therapy in cardiovascular disease: Current status and future directions
    Passacquale, Gabriella
    Sharma, Pankaj
    Perera, Divaka
    Ferro, Albert
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (06) : 2686 - 2699